PALB2 deletion
|
Prostate Cancer
|
PALB2 deletion
|
Prostate Cancer
|
olaparib Sensitive: C3 – Early Trials
|
olaparib Sensitive: C3 – Early Trials
|
PALB2 deletion
|
Uterine Corpus Leiomyosarcoma
|
PALB2 deletion
|
Uterine Corpus Leiomyosarcoma
|
olaparib Sensitive: C3 – Early Trials
|
olaparib Sensitive: C3 – Early Trials
|
PALB2 deletion
|
Endometrial Cancer
|
PALB2 deletion
|
Endometrial Cancer
|
olaparib Sensitive: C4 – Case Studies
|
olaparib Sensitive: C4 – Case Studies
|